| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/15/2007 | US20070037141 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 02/15/2007 | US20070036725 Imaging of protease activity in live cells using activity based probes |
| 02/15/2007 | CA2618750A1 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 02/15/2007 | CA2613482A1 Methods and compositions for diagnosis and treatment of influenza |
| 02/14/2007 | EP1752467A1 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 02/14/2007 | EP1751300A2 T-cell death-inducing epitopes |
| 02/14/2007 | EP1751107A1 Process for the preparation of perindopril |
| 02/14/2007 | EP1750528A2 Alpha-msh-antagonist didpeptide conjugates |
| 02/14/2007 | CN1914225A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1911921A Method for identification of tumor targeting enzymes |
| 02/14/2007 | CN1300328C Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176278 Modified transferrin fusion proteins |
| 02/13/2007 | US7176208 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 02/13/2007 | US7176185 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid |
| 02/13/2007 | US7175679 Modulating expression of a gene in a cell comprising providing the cell with a signaling molecule comprising a peptide |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/08/2007 | WO2007016476A2 Hepatitis c serine protease inhibitors and uses therefor |
| 02/08/2007 | WO2007016441A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007016364A2 Peptide deformylase inhibitors |
| 02/08/2007 | WO2007015855A1 Hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007015824A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | WO2007015787A1 Hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007014926A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014925A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014924A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014921A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014920A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014919A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014918A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2006114774A3 Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 02/08/2007 | WO2006066598A3 Antibody binding affinity ligands |
| 02/08/2007 | WO2005122379A3 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032437 Iap binding compounds |
| 02/08/2007 | US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070032431 laminin binding site |
| 02/08/2007 | US20070032406 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2007 | US20070032405 Branched water-soluble polymers and their conjugates |
| 02/08/2007 | US20070031879 Novel enterokinase cleavage sequences |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | CA2617095A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2616954A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2615666A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1749022A2 Methods for cyclizing synthetic polymers |
| 02/07/2007 | EP1749007A2 Macrocyclic compounds as inhibitors of viral replication |
| 02/07/2007 | EP1748992A1 Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives |
| 02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 02/07/2007 | EP1457498B1 Novel peptide having angiotensin convertase inhibitory effect |
| 02/07/2007 | CN1908009A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1908008A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1298737C Synthesis method of dipeptide containing L-glutamine |
| 02/07/2007 | CN1298729C Modular peptide-based reagent |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/06/2007 | US7173107 Glycopeptide and preparation thereof |
| 02/06/2007 | US7173106 Potent and highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds; method for selecting potent inhibitors of insect calcium channels |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/06/2007 | US7173041 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 02/06/2007 | US7173013 Administering a peptide compound |
| 02/06/2007 | US7173012 Hypoglycaemic peptides and methods of use thereof |
| 02/06/2007 | US7173011 Radiation therapy methods |
| 02/06/2007 | US7173004 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus |
| 02/06/2007 | US7172751 D-amino acid peptides |
| 02/01/2007 | WO2007014193A2 Peptidyl diacylglycerides |
| 02/01/2007 | WO2007012849A2 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
| 02/01/2007 | WO2007012838A2 Drug delivery system |
| 02/01/2007 | WO2006131586B1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/01/2007 | WO2006078746A3 Method, compositions and classification for tumor diagnostics and treatment |
| 02/01/2007 | WO2004003005A3 Sh2 domain binding inhibitors |
| 02/01/2007 | WO2003058203A3 Extended glucagon-like peptide-1 analogs |
| 02/01/2007 | US20070027326 Process for the manufacture of an enantiopure compound |
| 02/01/2007 | US20070027088 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock |
| 02/01/2007 | US20070027087 Methods for preventing mitochondrial permeability transition |
| 02/01/2007 | US20070027071 HCV NS3 protease inhibitors |
| 02/01/2007 | US20070026478 Hemiasterlin affinity probes and their uses |
| 02/01/2007 | CA2616985A1 Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-i-yl methylene or a pyrimidin-2yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group |
| 02/01/2007 | CA2616803A1 Peptidyl diacylglycerides |
| 02/01/2007 | CA2616521A1 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 01/31/2007 | CN1906209A Stabilized alpha helical peptides and uses thereof |
| 01/31/2007 | CN1906208A Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 01/31/2007 | CN1905893A Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| 01/30/2007 | US7169919 Genetically engineered lipids for use in the treatment baterial infection |
| 01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 01/30/2007 | US7169891 Human pellino polypeptides |
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169752 Covalently bonding at 6' position and 14' position of oxycodone a single amino acid or oligopeptide of 12 or fewer amino acids; when delivered at proper dosage composition provides therapeutic activity similar to that of parent active agent; when delivered at higher dose potential for overdose is reduced |
| 01/30/2007 | US7169576 Incubating the drug candidate in vitro with a human liver microsome incubation mixture in the presence of dansylated glutathione; detecting any drug candidate-dansylated glutathione adducts formed using a fluorescence detector |